Cite

HARVARD Citation

    Schaffer, M. et al. (2018). Identification of potential ibrutinib combinations in hematological malignancies using a combination high-throughput screen. Leukemia & lymphoma. 59 (4), pp. 931-940. [Online]. 
  
Back to record